Riskpilot← Back to searchSign inGet full accessUllmed AB
ABActiveOrg 5568235963Sonja Kovalevskys Gata 8General medical practice activities · NACE 8621Est. 20101-4 employees
Revenue 2024
SEK 2,2M
0% vs 2023
EBITDA margin
41.5%
+3% vs 2023
Equity ratio
21.4%
Financial strength
Net profit 2024
SEK 651K
+125% vs 2023
| Revenue | SEK 2,2M | +0% |
| EBITDA | SEK 914K | +3% |
| Net profit | SEK 651K | +125% |
| Total assets | SEK 13,6M | +0% |
| Equity | SEK 2,9M | +29% |
| Employees | — | — |
Legal name
Ullmed AB
Org number
5568235963
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
3 november 2010
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolagets verksamhet är att bedriva anestesitjänster, flyg- och dykmedicinska undersökningar, produktion av AV material, samt närliggande verksamhet.
Address
Sonja Kovalevskys Gata 8
Phone
+46707306254
Email
info@ullmed.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 995 | 2 184 | 1 982 | 2 196 | 2 203 |
| Staff expenses | — | — | −616 | −814 | −823 |
| EBITDA | 965 | 1 202 | 1 093 | 886 | 914 |
| Depreciation & amort. | −157 | −159 | −175 | −6 | −227 |
| EBIT | 808 | 1 043 | 918 | 880 | 687 |
| Net financials | −323 | −352 | −339 | −350 | −336 |
| Profit before tax | 485 | 781 | 424 | 382 | 833 |
| Tax | −110 | −169 | −99 | −92 | −183 |
| Net profit | 375 | 612 | 326 | 290 | 651 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 13 260 | 13 321 | 13 518 | 13 629 | 13 634 |
| Equity | 1 036 | 1 647 | 1 973 | 2 263 | 2 913 |
| Long-term debt | 10 171 | 9 816 | 10 345 | 10 203 | 10 138 |
| Short-term debt | 1 783 | 1 677 | 865 | 680 | 583 |
| Total debt | 11 954 | 11 493 | 11 210 | 10 883 | 10 721 |
EBITDA margin
41.5%
This company
15.8%
Market median
+163% vs market
20202024
Equity ratio
21.4%
This company
38.2%
Market median
-44% vs market
20202024
Return on equity
22.3%
This company
18.4%
Market median
+21% vs market
20202024
Net profit margin
29.5%
This company
8.1%
Market median
+264% vs market
20202024
Asset turnover
0.16×
This company
1.12×
Market median
-86% vs market
20202024
Debt / equity
3.68×
This company
0.62×
Market median
-494% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ullmed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Henrik Widén | Deputy Board Member | 0 companies |
| Peter Carl Wilhelm Stenson Ullström | Board of Directors | 0 companies |
| Ester Anna Margareta Ullström | Deputy Board Member | 0 companies |